FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)
Public ClinicalTrials.gov record NCT03422510. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multicenter, Open Label, Randomized Study of Two Titration Regimens of Oral CXA-10 in Subjects With Primary Focal Segmental Glomerulosclerosis (FSGS)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, open label, randomized study investigating two dose titration regimens of CXA-10 in subjects at least 18 years of age with primary FSGS. The study will be performed at approximately 25 study centers across the United States of America (USA). The recruitment period is anticipated to be up to approximately 16 months. Approximately 30 subjects will be randomized to ensure 26 subjects complete the study. An optional 9 month open label is available
Study identification
- NCT ID
- NCT03422510
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 33 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 13 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 14, 2018
- Primary completion
- Jul 30, 2020
- Completion
- Jul 30, 2020
- Last update posted
- Aug 2, 2020
2018 – 2020
United States locations
- U.S. sites
- 24
- U.S. states
- 17
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Neurology Consultants | Huntsville | Alabama | 35805 | — |
| Cedars Sinai Medical Center | Los Angeles | California | 90048-9978 | — |
| Stanford University | Palo Alto | California | 94304 | — |
| A.I. duPont Hospital for Children | Wilmington | Delaware | 19803 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Nephrology Associates of Northern Illinois and Indiana (NANI) | Chicago | Illinois | 60521 | — |
| Northwest Louisiana Nephrology | Shreveport | Louisiana | 71101 | — |
| Kidney Care and Transplant Services of New England | Springfield | Massachusetts | 01107 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| St. Clair Nephrology Research | Roseville | Michigan | 48066 | — |
| Clinical Research Consultants-KCMO | Kansas City | Missouri | 64111 | — |
| Albert Einstein College of Medicine, Montefiore | The Bronx | New York | 10461 | — |
| Metrolina Nephrology Associates | Charlotte | North Carolina | 28204 | — |
| Levine Children's Hospital | Charlotte | North Carolina | 28207 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Northeast Clinical Research Center (NCRC) | Bethlehem | Pennsylvania | 18017 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Nephrology Associates | Franklin | Tennessee | 37205 | — |
| Texas Tech | Amarillo | Texas | 79106 | — |
| Renal Disease Research Institute | DeSoto | Texas | 75115 | — |
| El Paso Medical Research | El Paso | Texas | 79935 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| The Polyclinic | Seattle | Washington | 98104 | — |
| Providence Sacred Heart Medical Center and Children's Hospital | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03422510, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 2, 2020 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03422510 live on ClinicalTrials.gov.